May 16, 2011 -- Takeda Pharma of Japan wants to grow its China revenues by more than 10 times before the end of 2015, according to the company’s President, Yasuchika Hasegawa. It currently produces 3 billion yen ($37 million) of sales in the PRC. To accomplish its goals, the company will invest “several tens of billions of yen” in China over the next few years – with each ten billion yen worth about $124 million. Takeda will also increase its sales force from 250 representatives to 900. More details....
Stock Symbol: (TO: 4502)
